Scott R. Pancoast - Jun 30, 2021 Form 4 Insider Report for DermTech, Inc. (DMTK)

Role
Director
Signature
/s/ Jason S. Miller, attorney-in-fact
Stock symbol
DMTK
Transactions as of
Jun 30, 2021
Transactions value $
-$212,051
Form type
4
Date filed
7/2/2021, 08:50 PM
Previous filing
May 28, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Sale -$195K -4.61K -8.64% $42.32* 48.7K Jun 30, 2021 Direct F1, F2
transaction DMTK Common Stock Sale -$17.1K -394 -0.81% $43.50* 48.3K Jun 30, 2021 Direct F1
transaction DMTK Common Stock Award $0 +2.41K +4.98% $0.00 50.7K Jul 1, 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Scott R. Pancoast is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $42.08 to $42.85, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of issuer common stock. The award will vest in full and be released at the next annual meeting of stockholders of the Company.